Health Condition 1: G448- Other specified headache syndromes
Conditions
Interventions
Intervention1: Oreodaphne Californica: Oreodaphne californica is a homoeopathic medicine which will be administered orally on the basis of symptom similarity. Medicine will be Given in 30c thrice a da
Sponsors
Dr Giredra Pal Homoeopathic Hospital and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who have given consent for the study. 2.Patient of 15-65 age group and all sexes will be included. 3.Previously diagnosed cases of headache, and patient is ready to stop all other medical treatment. 4.Patient suffering from sign and symptoms suggestive of headache irrespective of diagnosis . 5.Patients who are having following symptoms of headache as mentioned in A DICTIONARY OF PRACTICAL MATERIA MEDICA-JH CLARKE shall be enrolled for the study irrespective of diagnosis- OREODAPHNE CALIFORNICA 1.Confusion of head. Dizziness agg. on stooping and moving about. 2.Dull ,pressive fronto-occipital headache; ameli.after night ,rest. 3.Internal aching with pressure at inner angle of orbit especially left never in both simultaneously ,extends through brain and across scalp to base of occiput; lasted for 30min to 7 hours. 4.agg. by light; noise; motion; ameli. closing eyes, and perfect quiet should be given oreodaphne californica. SCUTELLARIA LATEROFOLIA 1.Vertigo : soon after breakfast ; with photophobia. 2.Dull oppressive headache ; on rising ;aggra. study. 3.Full, throbbing sensation in head.-Sensation as if cranial contents were confined in too small a space. 4.Before rising, hemicrani, most severe over right eye ;amelio. moving about in open air. 5.Pain in occiput.-headache
Exclusion criteria
Exclusion criteria: 1.Cases which require emergency treatment. 2.Patient pursuing other treatment and were not willing to leave it. 3.Pregnant women and lactating mothers will not be included in the study. 4.Immuno compromised patient such as suffering from HIV, Hepatitis B/C etc. 5.Cases with multi systemic illness will be excluded from the study and case with advance pathology.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in VAS Score will be noted pre, during and post treatment and shall be analyzed to assess the efficacy of treatment .Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To verify the symptoms of Oreodaphne californica and scutellaria laterifolia as mentioned dictionary of practical materia medica by-Jh clarke.Seconday outcome will be assessed before ,during and after VAS score for pain management.Timepoint: 1 YEAR | — |
Countries
India
Contacts
Public ContactDr Yasha soni
Dr MPK Homoeopathic Medical College Hospital and Research Centre
Outcome results
None listed